Sandy Spring Bank trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 8.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 109,212 shares of the biopharmaceutical company’s stock after selling 9,726 shares during the quarter. Sandy Spring Bank’s holdings in […] Read this story